1. Hims & Hers Health, Inc. (HIMS) reported $1.5 billion in revenue in 2024, with a 69% year-over-year increase and $126 million in GAAP net income. 2. The company's subscriber base reached 2.2 million, growing 45% year-over-year, with 55% of subscribers using at least one personalized treatment. 3. Hims & Hers' GLP-1 weight loss treatments contributed $225 million in incremental revenue, but regulatory and supply risks remain significant concerns.
Related Articles
- October 2025 Perspectiveabout 1 month ago
 - CoreWeave's AI Climb Still Hides Untapped Firepowerabout 1 month ago
 - IonQ: Near-Term Revenue Analysis, Long Runway For Price Increaseabout 1 month ago
 - Micron Technology, Inc. (MU) Q4 2025 Earnings Call Transcriptabout 1 month ago
 - ASML Holding: $1.5B Mistral AI Misfireabout 2 months ago
 - Housing: 5 More Signs Of A Rapidly Deteriorating Market2 months ago
 - Cenovus Energy's MEG Energy Acquisition: More Double-Digit Dividend Growth In The Future Likely2 months ago
 - Upstart: GAAP Inflection Point3 months ago
 - SCHD Vs. VIG: Which One Is Better?3 months ago
 - Applied Materials Announces Third Quarter 2025 Results3 months ago